Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ·Healthcare·Biotechnology
$38.32
+1.05%
Mkt Cap $2.10B
Analyst Ratings
Buy
6
Hold
3
Sell
0
Price Target (27 analysts)
$49.00
Range $34.00 – $70.00
Implied Upside
+27.9%
Consensus $49.00 vs current $38.32